Watch Ticker

Arcellx, Inc. Common Stock

Go to Arcellx, Inc. Common Stock Website

$72.08

0.94 (1.32%)

Live

Previous Close

$71.14

Day Range

$70.125 - $72.98

Previous Day Range

$70.46 - $72.2

Market Cap

$3.9 billion USD

Day Vol.

238009

Previous Day Vol.

330989

Currency

USD

Primary Exchange

Nasdaq

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs

The article discusses the growing cancer treatment market, with a focus on companies like Oncolytics Biotech, Akoya Biosciences, Quanterix, TScan Therapeutics, and Arcellx. It highlights new data and collaborations that signal a turning point for precision-driven cancer biotechs.

Related tickers: ONCY, AKYA, QTRX, TCRX, ACLX.

Read Full Article

Delveinsight - Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight

The blood cancer market is experiencing robust growth, driven by rising incidence rates and advancements in targeted therapies and immuno-oncology. Increasing adoption of CAR-T cell therapies, monoclonal antibodies, and personalized medicine is transforming treatment outcomes.

Related tickers: ABBV, SLS, MRK, AAPG, JNJ, ADCT, BMY, CELGr, REGN, RHHBY, ACLX, KROS, SYRS, BGNE, ONC.

Read Full Article

Trending Tickers

Please sign in to view